Ardent Health (NYSE:ARDT) Issues Quarterly Earnings Results

Ardent Health (NYSE:ARDT) posted its quarterly earnings data on Wednesday. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.08, FiscalAI reports. The company had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.60 billion. Ardent Health had a net margin of 2.27% and a return on equity of 8.49%.

Ardent Health Stock Performance

Shares of ARDT traded up $1.32 during midday trading on Friday, reaching $17.23. The stock had a trading volume of 3,465,521 shares, compared to its average volume of 478,484. The firm has a 50 day simple moving average of $11.32 and a 200-day simple moving average of $10.05. Ardent Health has a one year low of $7.71 and a one year high of $17.67. The firm has a market cap of $2.43 billion, a PE ratio of 16.72, a P/E/G ratio of 3.68 and a beta of 0.58. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61.

Analyst Ratings Changes

Several research firms recently issued reports on ARDT. Guggenheim upped their target price on Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Truist Financial raised their price target on Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Weiss Ratings upgraded Ardent Health from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, October 6th. BMO Capital Markets began coverage on Ardent Health in a research report on Tuesday, September 22nd. They set a “market perform” rating and a $11.00 price target on the stock. Finally, Stephens upped their price objective on Ardent Health from $13.00 to $21.00 and gave the stock an “overweight” rating in a research note on Friday. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Ardent Health presently has an average rating of “Hold” and a consensus target price of $13.54.

Key Headlines Impacting Ardent Health

Here are the key news stories impacting Ardent Health this week:

• Positive Sentiment: Ardent reported Q3 earnings of $0.31 per share, ahead of analyst estimates of roughly $0.23–$0.24, and revenue of $1.625 billion versus the $1.60 billion consensus. Recent coverage also highlighted a return to profitability and improved guidance. Zacks Q3 earnings report Profit and guidance coverage
• Positive Sentiment: Stephens raised its price target to $21 from $13 and maintained an Overweight rating, implying further potential upside from the quoted $17.23 share price. Stephens ratings
• Positive Sentiment: RBC lifted its target to $18 from $13 and reiterated an Outperform rating, signaling a more positive view after the results. RBC ratings
• Neutral Sentiment: The strong rally has brought the stock close to its 12-month high, and a recent analysis questioned whether shares may already be above fair value. That could limit further gains if investors have priced in the earnings beat and raised outlook. Valuation analysis
• Negative Sentiment: Despite beating estimates, quarterly EPS was below the $0.52 reported a year earlier, pointing to year-over-year earnings pressure. Zacks earnings comparison

About Ardent Health

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.